Navigation Links
Study finds greater potential benefit in overall survival for eribulin compared with capecitabine
Date:6/12/2013

(Lebanon, NH, 6/11/13) Subgroup analyses from a phase III clinical trial comparing a newer chemotherapy agent called eribulin mesylate, with capecitabine, a standard chemotherapy medication in women with previously treated metastatic breast cancer, showed increased benefit among women sharing certain traits. Specifically, these analyses demonstrated a greater potential benefit in certain subsets of patients with metastatic breast cancer. This analysis was presented by Peter A. Kaufman, M.D., during the 2013 ASCO Annual Meeting.

The specific patient populations who appeared to benefit from eribulin, in comparison to capecitabine, are as follows:

  • Patients with more than two organs involved with metastatic breast cancer
  • Patients who had not received chemotherapy for six months or longer
  • Patients who had received anthracycline and/or a taxane therapies in the metastatic setting

Previous pre-specified exploratory analysis of overall survival and progression-free survival showed women with triple-negative, ER-negative, HER2-negative also had a greater relative benefit in overall survival with eribulin over capecitabine.

"These exploratory analyses suggest that other patient subgroups may benefit from eribulin and further studies are warranted," said Peter A. Kaufman, MD, associate professor of medicine at the Geisel School of Medicine at Dartmouth, and oncologist at Dartmouth-Hitchcock and Norris Cotton Cancer Center in Lebanon, N.H.

In 2010, the FDA approved eribulin for the treatment of patients with metastatic breast cancer who had previously received an anthracycline and a taxane and at least two cytotoxic chemotherapy treatment regimens for metastatic breast cancer. The FDA granted approval based on data showing a statistically significant improvement in overall survival compared with current treatments.

Kaufman and colleagues are still compiling data from the quality-
'/>"/>

Contact: Donna Dubuc
donna.m.dubuc@hitchcock.org
603-653-3615
Dartmouth-Hitchcock Medical Center
Source:Eurekalert

Page: 1 2

Related medicine news :

1. New Study Links Poor Sleep and Prostate Cancer
2. Researcher awarded grant to study food insecurity in homes of child with special healthcare needs
3. Study finds cancer guidelines do not fully meet IOM standards
4. Our Lady of Lourdes Medical Center & The Heart House Participating in Research Study Using Adult Stem Cells for Chronic Cardiac Condition
5. High Bit Security: 2/3 of All Data Breaches Preventable With Proactive Security Testing, New Ponemon Institute Study Documents Breach Causes and Costs
6. Alzheimer's Pilot Study Proposed for Ustekinumab (Stelara)
7. Capital Health Institute's Study Shows Migraine Headaches Prevalent Among Teen Girls
8. Workers do not quit due to mandatory flu shot, says Loyola study
9. Study finds obese mothers program their kids to be fat, but legacy can be overturned
10. Study shows cardiac MRI use reduces adverse events for patients with acute chest pain
11. Great HealthWorks, Makers of Omega XL, Report on New Omega-3 Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/13/2014)... Va. (PRWEB) September 13, 2014 Happiness is ... to healthier living and achieving goals. That's what LWell ... pleased to announce that Stephens, a life coach who has ... was a teenager, will present her "Happiness is a Choice" ... 6:30 p.m. , This event is being offered ...
(Date:9/13/2014)... MD (PRWEB) September 13, 2014 Deaf Awareness ... The Hearing and Speech Agency hosts a week-long ... Sign Language (ASL) as the main form of communication. ... the schedule includes an ASL film night, a yoga class, ... open to the entire community. , The schedule is as ...
(Date:9/13/2014)... (PRWEB) September 13, 2014 Motion Graphics artist ... new transition pack entitled TransPack Volume 2 exclusively for Final ... fun way to transition from one clip to the next.” ... can never have too many transition options and TransPack Volume ... TransPack Volume 2 is a package of 30 thematic transitions ...
(Date:9/13/2014)... September 13, 2014 Although it’s cooled ... into mosquito high season are the state’s southern cities ... areas. With a rise in mosquitoes carrying West ... a partnership with Dixie State University’s Dr. Barnum and ... a product called NutriVex. , NutriVex is in its ...
(Date:9/12/2014)... As low testosterone lawsuit claims continue ... two of the U.S. Food & Drug Administration (FDA) ... to discuss controversial public health issues surrounding testosterone replacement ... and the Drug Safety and Risk Management Advisory Committee ... population for testosterone replacement therapy and the potential risk ...
Breaking Medicine News(10 mins):Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 2Health News:“Happiness is a Choice” Life Coaching Seminar Open to Community 3Health News:Baltimore Nonprofit Celebrates Deaf Awareness Week 2Health News:Baltimore Nonprofit Celebrates Deaf Awareness Week 3Health News:Today a new TransPack Volume 2 transition was announced from Pixel Film Studios for Final Cut Pro X. 2Health News:Dixie State University Partners with Utah Marketing Firm and the SW Mosquito Abatement and Control District for Product Testing 2Health News:Dixie State University Partners with Utah Marketing Firm and the SW Mosquito Abatement and Control District for Product Testing 3Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 2Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 3Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 4Health News:Testosterone Lawsuit Claims Continue As FDA Holds Meeting On Health Risks Associated "Low-T" Drugs Such As AndroGel 5
... Organisation (WHO) Monday hailed the progress of governments of Western ... region needed greater effort to effectively control the disease. ... of detecting at least 70 percent of TB cases and ... Maaren, regional adviser for the health body's TB programme. ...
... miniature robot that can be inserted through an incision ... body. ,Researchers from Ritsumeikan University and the ... that is controlled remotely once placed inside the body. ... centimeters (0.79 inches) in length and one in diameter. ...
... that some patients who complete bariatric surgery can develop ... deficiency, called Wernicke encephalopathy. , The researchers ... about their conclusions by extensive survey of data relating ... surgery. , The syndrome - Wernicke encephalopathy ...
... inhaled anesthetics increase the number of amyloid plaques in ... of neurodegenerative diseases like Alzheimer's. ,Roderic Eckenhoff, ... Pennsylvania's Department of Anesthesia and Critical Care, and his ... edition of Neurobiology of Aging. ,Every year ...
... hardly 29 per cent of the asthmatic children surveyed had ... as a dangerous trend for not vaccinating their kids against ... officials have warned. ,Actually it has been warned ... fall victims to pneumonia or acute respiratory disease. Inactivated flu ...
... possibly hazardous chemicals called polybrominated diphenyl ethers (PBDEs). The ... and Technology and the Environmental Protection Agency of the ... clear how dangerous these PBDEs are, though some types ... is strikingly similar to that of PCBs, which are ...
Cached Medicine News:Health News:WHO Calls for Greater Efforts to Fight TB 2Health News:Inhaled Anesthetics Accelerate the Onset of Neurodegenerative Diseases Like Alzheimer's 2
(Date:9/12/2014)... , Sept. 12, 2014 Research ... "Global Diclofenac Industry Report 2014" report to ... Report 2014 is a professional and in-depth study on ... The report provides a basic overview of ... structure. The diclofenac market analysis is provided for the ...
(Date:9/12/2014)... -- Research and Markets  has announced the addition of ... & Forecast - Worldwide" report to their offering. ... women in both the developed and developing world. Worldwide Breast ... 2013. United States is the leading ... is expected to maintain its 2nd position in the ...
(Date:9/12/2014)... -- According to the new research report "Point-Of-Care Diagnostics ... Diseases Testing Kits, Cardiac & Tumor Markers), by End ... Prescription Based - Global Forecast to 2018" published by ... the forecast period of 2013 to 2018. The market ... from 2013 to 2018, to reach $27.5 billion by ...
Breaking Medicine Technology:Global Diclofenac Industry Report 2014 2Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 2Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 3Breast Cancer Screening (Mammography, MRI & Ultrasound) Market & Forecast - Worldwide 4Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 2Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 3Point-Of-Care Diagnostic Market Worth $27.5 Billion by 2018 4
... GoodRx today announced that it has created ... with accurate drug prices from virtually every U.S. pharmacy. GoodRx, ... iphone app , allows consumers to compare drug prices, which ... coupons and savings tips. Consumers simply enter ...
... (NASDAQ: HALO ) today announced the completion of ... stock, including 1,020,000 shares sold pursuant to the full exercise ... of the shares were offered by Halozyme at a price ... Halozyme from this offering were approximately $81.8 million, after deducting ...
Cached Medicine Technology:GoodRx™ Brings Price Transparency to Prescription Drugs 2GoodRx™ Brings Price Transparency to Prescription Drugs 3GoodRx™ Brings Price Transparency to Prescription Drugs 4Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock 2Halozyme Announces Exercise in Full of Over-Allotment Option and Completion of Public Offering of Stock 3
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
Medicine Products: